二氧化锰氧化制备聚苯胺及其超级电容性能

以二氧化锰为氧化剂在酸水体系中化学氧化制备了聚苯胺（PANI）,考察了聚合条件对产率的影响。采用红外光谱、扫描电镜等手段对PANI的结构与形貌进行了表征,采用电化学工作站对其电化学电容性能进行了测试。结果表明：PANI产率随着体系中氧化剂用量的增加、苯胺用量的减少、反应温度的降低和反应时间的延长而增加,制备的聚苯胺主要是翡翠亚胺型聚苯胺,并以颗粒形式存在,大小在100 nm左右,局部有团聚现象,颗粒间堆积蓬松;该聚苯胺作为超级电容器活性电极材料,具有较好的电化学电容性能,最高比电容达到178 F/g。     

聚苯胺/纳米二氧化锰复合材料Ⅰ.原位氧化合成制备

用固相合成法制备了纳米二氧化锰(nm-MnO2),并通过原位聚合法制备了聚苯胺／纳米二氧化锰复合材料。研究结果表明：在苯胺／nm-MnO2的盐酸反应体系中,nm-MnO2可以使苯胺氧化聚合。在一定的nm-MnO2用量下,聚苯胺的产率随苯胺添加量的增加而下降,nm-MnO2在产物中的含量也随之下降,且含量很低。在苯胺：／nm-MnO2／过硫酸铵的反应体系中,研究了Nm-MnO2通过两种不同的加料方式原位制备PA-NI／nm-MnO2复合材料的合成条件。第一种方式为nm-MnO2和过硫酸铵同时与苯胺混合,一起参与苯胺的氧化聚合。第二种方法是先将过硫酸铵和苯胺混合,3min后再将nm-MnO2加入反应体系中。研究表明：第一种加料方式得到的队NI／nm-MnO2中nm-MnO2的含量很低;第二种加料方式可以得到高nm-MnO2含量(w=0．14-0．73)的产物,其电导率约10^-4S／cm。     

氧化剂用量和酸浓度对聚苯胺纳米纤维结构和电性能的影响

采用界面聚合法制备了聚苯胺纳米纤维,详细研究了不同氧化剂／单体摩尔比和盐酸浓度对制得聚苯胺的形貌、分子结构和电导率的影响。结果表明：界面聚合过程中,较低的氧化剂／单体摩尔比（≤1：4）和较高的盐酸浓度（≥1mol／L）有利于生成结构规整和较高电导率的聚苯胺纤维;而在氧化剂用量较高和盐酸浓度较低时,聚苯胺纤维形成的同时,伴随着吩嗪类物质和苯胺齐聚物的生成,产物呈现聚集结构,其电导率也较低。     

掺杂质子酸的类型对聚苯胺结构和电导率的影响

采用化学氧化聚合法以苯胺为单体，过硫酸铵为氧化剂，在不同质子酸的水溶液中合成聚苯胺，考察质子酸对聚苯胺电性能影响，并通过傅立叶红外吸收光谱（FTIR）和紫外可见光吸收光谱（UV－vis)研究聚苯胺掺杂前后结构的变化。结果表明，龙质子酸掺杂后聚 胺具有导电性是因为其分子链上电荷离城形成了共轭结构，具有不同质子酸中生成的聚苯胺氧化程度不同；分子链共轭程度与掺杂酸对阴离子大小有关，掺杂质子酸对阴离子越大，聚苯胺分子链共轭程度越大，电导率也就越高。     

分散剂类型对聚苯胺粒径分布和电化学特性的影响

采用化学氧化聚合法以苯胺为单体、过硫酸铵为氧化剂,在不同分散剂体系中合成聚苯胺,考察分散剂对聚苯胺性能的影响。通过激光粒度仪、傅里叶红外吸收光谱、四探针电阻仪和电化学工作站等测试手段研究聚苯胺的结构、导电性、粒径分布及电化学性能。结果表明：分散剂能降低聚苯胺的粒径分布,提高聚苯胺的导电性和电化学稳定性;当分散剂聚乙二醇占苯胺单体质量的20%时,聚苯胺的平均粒径为3.85 μm,导电率为4.68 S/cm,极化电位为0.73 V。     

聚苯乙烯磺酸掺杂聚苯胺的性能

以苯胺为单体，过硫酸铵(APS)为氧化剂，在聚苯乙烯磺酸(PSSA)的水溶液中，合成了PSSA掺杂的聚苯胺。通过FTIR、元素分析和热重分析等对产物的结构和性能进行了研究。结果表明：该法合成的PSSA掺杂聚苯胺可完全溶于水,具有较高的特性粘数、电导率、耐热性。     

基体表面性质对原位聚合沉积导电聚苯胺薄膜性能的影响

以水溶性高分子聚乙烯吡咯烷酮(PVP)为空间稳定剂,在经十八烷基三氯硅烷(OTS)改性的玻璃表面进行原位聚合,沉积得到导电聚苯胺(PANI)薄膜。采用表面界面张力仪、扫描电镜(SEM)、紫外可见光谱(UV-Vis)、红外光谱(FT-IR)、四探针电导率测试仪及光学显微镜对不同基体表面的接触角、PANI膜的形貌、厚度、结构、导电性及其在亲/憎水表面选择性沉积性能进行测定。结果表明:OTS对玻璃表面的改性促进了聚苯胺的沉积且提高了薄膜厚度,薄膜饱和厚度达到200 nm;缩短了溶液中苯胺分散聚合的诱导期,反应速率增大;与未改性玻璃表面沉积的薄膜相比,改性的玻璃表面得到的聚苯胺薄膜更加细密均匀,聚苯胺颗粒尺寸小,堆积紧密;薄膜的电导率达到7.5×10-3S/cm;OTS改性对基体表面的薄膜生长和溶液中的苯胺聚合具有催化作用。     

聚苯胺/纳米二氧化锰复合材料Ⅱ.形貌表征

通过先用过硫酸铵引发苯胺的聚合,然后再将纳米二氧化锰(nm-MnO2)加入过硫酸铵和苯胺的反应体系中。原住制备了导电聚苯胺／纳米二氧化锰复合材料(PANL／nm-MnO2),并有效地避免了nm-MnO2在苯胺氧化聚合中的消耗。扫描电镜和透射电镜显示复合材料中nm-MnO2为聚苯胺所包裹。X射线衍射研究表明,在复合材料制备过程中nm-MnO2的晶型未发生变化,在复合材料中聚苯胺为非晶相结构。     

聚苯胺/碳化钨导电复合材料的合成

以苯胺和过硫酸胺为原料,采用原位聚合方法合成了聚苯胺/碳化钨(PANI/WC)导电复合材料。研究了反应体系中碳化钨的含量对复合材料电导率的影响,确定了较佳的聚合条件,并且通过FT-IR、XRD、XPS和DSC-TGA等手段对复合材料的结构和性能进行了表征和分析。结果表明：碳化钨(WC)的加入提高了聚苯胺的电子导电性能,复合材料中聚苯胺组分为无定型, WC的晶型在反应前后并未发生变化,复合材料的热稳定性好并且质子化程度更高。     

聚苯胺/PA-6导电复合膜的电化学合成与性能

用电化学复合法，以聚己内酰胺为膜基，通过氟硼酸掺杂，使苯胺电解聚合，制成一种新型的聚苯胺／聚己内酰胺（ＰＡｎ／ＰＡ－６）复合膜，考察了电流密度、掺杂剂浓度及苯胺浓度等因素对导电复合膜的电导率、机械性能的影响。     

Value of D-Dimers in patients with acute aortic dissection

Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P ＜ 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (＞0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P ＜0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P ＜ 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.     

Research of combined liver-kidney transplantation model in rats

Objective： To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods： SD rats served as both donors and recipients. 4℃ sodium lactate Ringer＇s was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava （IVC） inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results： Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion： This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

Luo Lingjie's Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Dr.Zhang Ren's Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

安心颗粒对急诊经皮冠状动脉介入术后生活质量影响的研究

目的：评价使用安心颗粒对急诊经皮冠状动脉介入术（PPCI）术后生活质量的影响.方法：将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组（术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次）和对照组（仅接受基础药物治疗）.所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表（MIDAS）、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果：入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异（P＞0.05）;出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低（P＜0.05）;组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低（P＜0.05）.两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血（P＞0.05）.两组发生轻度血小板减少症的患者数比较无差异（P＞0.05）.结论：PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.     

The comparative studies of the influences of Urapidil and Nicardipine on sino-atrial node function, atrio-ventricular node function and hemodynamics

Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P＜0.01);the MAP decreased(P＜0.01)and the HR increased drastically(P＜0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.